$COEP NASDAQ: COEP: Potential acquisition of VyGen-Bio $COEP; Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics
https://finance.yahoo.com/news/coeptis-therap...00044.html